The participating regions are home to 84 percent of sickle cell Medicaid patients who could gain access to gene therapies under outcomes-based agreements.

Arcellx, Inc. advances anito-cel CAR-T therapy for relapsed/refractory multiple myeloma. Click for ACLX pivotal trials, FDA ...

Being cut off in traffic, giving a presentation or missing a meal can all trigger a suite of physiological changes that allows the body to react swiftly to stress or starvation.

Being cut off in traffic, giving a presentation or missing a meal can all trigger a suite of physiological changes that allow the body to react swiftly to stress or starvation. Critical to this "fight ...

Juri Biosciences is offering EpimAb up to $210 million biobucks for licensing rights to a T-cell engager designed to treat metastatic prostate cancer.

AGC Biologics supports the development of multiple Treg cell therapy drug candidates targeting severe immune disorders for Quell Therapeutics.

Phase 1 and 2 trials of immunomodulatory drugs test ways to quell cytotoxic T cells beckoned to the AD brain. Low dose IL-2 and a nasal anti-CD3 antibody aim to expand T regulatory cells. In one ...

A new chimeric antigen receptor (CAR) T cell therapy called AIC100, which targets the ICAM-1 protein, demonstrated encouraging responses and an acceptable safety profile in patients with two types ...

Egle Therapeutics unveils preclinical biodistribution data on EGL-001, a novel anti-CTLA4-IL2 mutein fusion antibody designed to selectively deplete tumor-infiltrating regulatory T cells (Tregs).

Renier Brentjens, a CAR T-cell pioneer, views armored CAR T-cells as a promising avenue for treating solid tumors and predicts that a treatment could be approved in the next 5-10 years.

Transmission electron microscopy (TEM) is well-known for performing in situ studies in the nanoscale. Hence, scientists took this opportunity to explore the subtle processes occurring in living ...

Engineered regulatory T cells were able to calm the gluten-reactive effector T cells that cause the autoimmune response seen in celiac disease.